Depression Rehab Centers


Depression Rehab Centers – Rehab.


Alkermes Announces Data on ALKS 5461 and ALKS 3831 to Be Presented at 53
Oral presentation: "Opioid Modulation: A Novel Mechanism for the Treatment of Depression: Results of the ALKS 5461 Phase 2 Study" will be given by Maurizio Fava, M.D., Director of the Depression Clinical and Research Program at Massachusetts General … Read more on Wall Street Journal (press release)

Vortioxetine clinical phase III data show significant improvement in symptoms
"It is important that we continue to seek new options in depression because, even though there are effective treatments available, many patients remain symptomatic," said Madhukar Trivedi, M.D., professor of psychiatry, UT Southwestern Medical Center. Read more on GlobeNewswire (press release)